Filing Flows › Comparisons › WGS vs OMDA
GeneDx Holdings vs Omada Health: WGS and OMDA compared
GeneDx Holdings is the larger company: $114M of revenue in its latest quarter (Q2 2026) against $91.3M for Omada Health (Q3 2026). Omada Health is growing faster (+34% against +11% a year earlier). Omada Health is more profitable, with an operating margin of 5.3% against -15.3%.
Where the money goes: WGS and OMDA
GeneDx Holdings (WGS) · Q2 2026
GeneDx Holdings, Q2 2026: revenue $114M (+11% year over year), operating margin -15.3%, net loss $17.7M, operating cash flow −$29.0M. The chart follows the revenue to costs, profit and cash.
Omada Health (OMDA) · Q3 2026
Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%, net earnings $6.6M, operating cash flow $15.1M. The chart follows the revenue to costs, profit and cash.
| GeneDx Holdings (WGS) | Omada Health (OMDA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $114M | $91.3M |
| Revenue growth, Y/Y | +11% | +34% |
| Gross margin | — | 75.9% |
| Operating margin | -15.3% | 5.3% |
| Net earnings | −$17.7M | $6.6M |
| Net margin | -15.5% | 7.2% |
| Operating cash flow | −$29.0M | $15.1M |
| Free cash flow | — | $15.0M |
| Market value | $2.0B | — |
| Analysts’ mean target | $93.50 | — |
Where the revenue comes from
GeneDx Holdings
- Diagnostic Test: $112M (98%)
- Other revenue: $2.6M (2%)
Omada Health
- Services: $85.1M (93%)
- Hardware: $6.2M (7%)
Questions
Which is bigger, GeneDx Holdings or Omada Health?
GeneDx Holdings is the larger company: $114M of revenue in its latest quarter (Q2 2026) against $91.3M for Omada Health (Q3 2026).
Is GeneDx Holdings or Omada Health growing faster?
Omada Health is growing faster (+34% against +11% a year earlier).
Which is more profitable, GeneDx Holdings or Omada Health?
Omada Health is more profitable, with an operating margin of 5.3% against -15.3%.
More: GeneDx Holdings earnings · how GeneDx Holdings makes money · Omada Health earnings · how Omada Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 3, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.